Filing Flows › GSK (GSK) › General Medicines revenue
GSK (GSK) General Medicines revenue by quarter
GSK's General Medicines revenue was $2.4B in Q3 2026 (third quarter 2026), +4% from Q2 2026. Over the last 5 quarters it ranged from $2.3B (Q1 2026) to $2.6B (Q2 2025).
| Quarter | General Medicines revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $2.4B | +4% | -1% |
| Q2 2026 | $2.3B | +4% | -9% |
| Q1 2026 | $2.3B | -8% | — |
| Q3 2025 | $2.5B | -4% | — |
| Q2 2025 | $2.6B | — | — |
Q3 2026 at a glance
GSK, Q3 2026: revenue $8.9B (+4% year over year), operating margin 23.9%, net earnings $1.5B, operating cash flow $3.1B. The chart follows the revenue to costs, profit and cash.
Questions
What is GSK's General Medicines revenue?
GSK's General Medicines revenue was $2.4B in Q3 2026 (third quarter 2026), +4% from Q2 2026.
How has GSK's General Medicines revenue changed?
Over the last 5 quarters it ranged from $2.3B (Q1 2026) to $2.6B (Q2 2025).